600211.SH
西藏药业
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 38.16
−2.13%Margins
Gross margin
93.8%
EBITDA margin
37.6%
EBIT margin
35.3%
Net margin
32.3%
FCF margin
35.6%
24.8%
Return on equity
15.1%
Return on assets
21.3%
Return on invested capital
0.47x
Asset turnover
CNY 1.1B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026